Lauren Pearson, DO, MPH

Associate Professor (Clinical), University of Utah School of Medicine

Education

• Master’s Degree—Public Health, Touro University California
• Medical Degree—Touro University California
• Residency—Anatomic and Clinical Pathology, Chief Resident, University of Vermont College of Medicine

Certification/Affiliations

• American Board of Pathology (Anatomic and Clinical)

Research Interests

• Community health
• Quality management and quality control

Recent Publications

• Pearson LN, Johnson SA, Greene DN, et al. Side-effects of COVID-19 on patient care: an INR story. J Appl Lab Med. 2021;6(4):953-961.
• Okoye NC, Barker AP, Curtis K, et al. Performance characteristics of BinaxNOW COVID-19 antigen card for screening asymptomatic individuals in a university setting. J Clin Microbiol. 2021;59(4):e03282-20.
• Pearson LN, Schmidt RL, Cahoon K, et al. Reliability of total nucleated cell counts in the setting of hip arthroplasty. J Appl Lab Med. 2020;6(3):679-687.
• Schmidt RL, Moore RA, Pearson LN. The costs and benefits of cross-level quality control rules. Clin Chim Acta. 2020;510:697-702.
• Pearson LN, Moser KA, Schmidt RL. D-dimer varies widely across instrument platforms and is not a reliable indicator of periprosthetic joint infections. Arthroplast Today. 2020;6(4):686-688.
• Goold E, Pearson L, Johnson LM. Can fecal calprotectin serve as a screen for necrotizing enterocolitis in infants? Clin Biochem. 2020;84:51-54.
• Schumacher JA, Holgard VD, Sial F, et al. Detection and quantification of FLT3 internal tandem duplication mutations do not vary significantly between whole blood and blast-enriched samples. Am J Clin Pathol. 2020;153(2):251-257.
• Walker BS, Pearson LN, Schmidt RL. An analysis of multirules for monitoring assay quality control. Lab Med. 2020;51(1):94-98.
• Schmidt RL, Pearson LN. Quality control optimization part II: a method to optimize the accuracy of laboratory quality control. Clin Chim Acta. 2019;495:233-238.
• Schmidt RL, Pearson LN. Quality control optimization part I: metrics for evaluating predictive performance of quality control. Clin Chim Acta. 2019;495:174-184.
• Metcalf RA, Calvaresi E, Tonna JE, et al. Severe intravascular hemolysis following extracorporeal right ventricular assist device placement. Transfusion. 2019;59(4):1178-1179.
• Schmidt RL, Pearson LN. Estimating the cost of quality of errors in the analytical phase. Clin Chim Acta. 2019;495:60-66.
• Pearson LN, Miller JM, Lunde JH, et al. Combined pathology-driven algorithmic testing and integrated reporting for bone marrow examination. Arch Pathol Lab Med. 2019;143(6):732-737.
• Schmidt RL, Pearson LN. Is your assay stable? Using process stability and capability to evaluate assay performance. Clin Chim Acta. 2019;490:28-33.
• Pearson LN, Schmidt RL. Adoption of evidence-based medicine in clinical laboratory science: a survey of the prevalence of systematic and narrative reviews. Lab Med. 2019;50(3):223-228.
• Lehman CM, Pearson L, Salmond J, et al. A reflex protocol for creatinine testing reduces costs and maintains patient safety. Lab Med. 2019;50(2):202-207.
• Adams A, Straseski JA, Lehman CM, et al. Peritoneal and pleural fluid chemistry measurements performed on three chemistry platforms. Lab Med. 2019;50(2):145-149.